The Difference between Traditional and AI Algorithms in Medtech: A Biostatistician’s Perspective
Software as a Medical Device now constitutes a substantial share of new medical device approvals, and the algorithms within these products span the full range from classical regression to deep learning. In the UK, software qualifying as a medical device falls under the Medical Devices Regulations 2002 as amended, with the MHRA providing specific guidance on software and artificial intelligence as a medical device. In the EU, standalone software…
Diagnostic, Prognostic, and Disease Monitoring Algorithms: What They Are and How Their Statistical Validation Differs
AI Algorithms now sit at every point in the patient pathway. They identify who has a disease, forecast what will happen next, and track change over time. The statistical machinery needed to validate each of these three types is fundamentally different. A model that classifies a patient as "disease-positive" at a single timepoint is not validated the same way as one that predicts 5-year survival. Neither maps neatly onto…
Quick Guide: Simulation Evidence for Frequentist Adaptive Designs in Medtech Clinical Trials
A fixed frequentist design, such as a standard two-arm randomised superiority study, generally does not require simulation. Its statistical properties come from established formulas. Closed-form or table-based power calculations tell you the sample size, and the Type I error rate follows from the test you specified. Simulation enters the picture when the study design gets messy in ways the standard formulas can't absorb, for instance complex survival endpoints, clustered…
High-Dimensional Data and Machine Learning for SaMD (Software as a Medical Device)
Series: Advanced Biostatistics for MedTech: Bridging Clinical Evaluation and Engineering The Regulatory Shift Toward Algorithmic Validation The integration of machine learning (ML) into Software as a Medical Device (SaMD), has fundamentally altered the regulatory landscape. The industry’s transition from the use of traditional statistical modeling (SM) to machine learning (ML) within device technology, has necessitated a paradigm shift in how predictive algorithms are validated. Under the EU Medical Device…
Can AI Automate a SAP?
Beneath the Surface of the Statistical Analysis Plan There is an emerging commercial narrative that AI can automate the drafting of a Statistical Analysis Plan (SAP) directly from a clinical protocol. Extract the endpoints, populate a template, link to table shells, and the plan is ready. For anyone who has lived through the hours behind the process of drafting a SAP, the appeal is immediate. The promise of a…
Variance Components and Mixed Models in Multi-Site Medical Device Studies
Series: Advanced Biostatistics for MedTech: Bridging Clinical Evaluation and Engineering The Complexity of Device Variability Under ISO 13485:2016 and MDR 2017/745 in the EU, medical device manufacturers must carefully control and validate their product manufacturing processes. A critical aspect of this validation is quantifying the sources of variability in the device's Critical Quality Attributes (CQAs). While pharmaceutical manufacturing controls unit-to-unit variation through content-uniformity and dissolution testing, inherent variability in…
Bayesian Adaptive Designs for Medical Device Clinical Investigations
Series: Advanced Biostatistics for MedTech: Bridging Clinical Evaluation and Engineering The Statistical Advantage of Iterative Medical Device Development Medical devices are iterative, physical, and engineerable. By the time a medical device reaches a pivotal clinical investigation, it has undergone extensive Verification and Validation (V&V) bench testing, biocompatibility assessments, and often animal studies. The physics of the device (such as its tensile strength, fatigue life, thermal dissipation, or sensor accuracy)…
Sample Size Justification in the Era of MDR: Navigating Power, Tolerance, and Assurance
Series: Advanced Biostatistics for MedTech: Bridging Clinical Evaluation and Engineering The Regulatory Rejection of "Industry Standard" Sample Size A frequently cited Major Non-Conformity in Notified Body audit reports under the EU Medical Device Regulation (MDR 2017/745) and IVDR 2017/746 is the inadequate statistical justification of sample size estimates. During design control reviews and Clinical Evaluation Report (CER) appraisals, technical reviewers consistently reject sample size rationale predicated on "historical precedent"…
Equivalence and Non-Inferiority Margins in 510(k) and CE Mark Submissions
Series: Advanced Biostatistics for MedTech: Bridging Clinical Evaluation and Engineering The Regulatory Trap of "Substantial Equivalence" Regulatory pathways for medical devices rely heavily on the concept of equivalence. Under the US FDA 510(k) framework, a manufacturer must demonstrate that a new device is "substantially equivalent" to a legally marketed predicate. In Europe, the EU Medical Device Regulation (MDR 2017/745) Article 61 requires clinical evaluation data to demonstrate equivalent safety…